Home » Business, Health & Medicine, News & Current Affairs, Technology » Cushing’s Syndrome Therapeutics Market To Grow At A CAGR Of 9.41 % By 2019: Radiant Insights
“Radiant Insights”
RadiantInsights.com has announced the addition of “Global Cushing’s Syndrome Therapeutics Market Trends, Growth And Forecast Report Up To 2019: Radiant Insights, Inc” Market Research Report to their Database.

About Cushing’s Syndrome

Cushing’s syndrome is a condition caused by the prolonged exposure to very high levels of cortisol. This can occur because of the consumption of glucocorticoid drugs or diseases that result in excess cortisol, ACTH, and CRH secretion. Harvey Cushing described the pathophysiology of this condition in 1932. It is more common in women than in men. Cushing’s syndrome is also known as hypercortisolism, hypercorticism, hyperadrenocorticism, or Itsenko-Cushing syndrome. Some of the common symptoms of Cushing’s syndrome are increase in weight, facial acne, cognitive disorders, and vulnerability to superficial fungus infections, growth of a mass around the collarbone or back of the neck, commonly known as the “”buffalo hump,”” and puffy face or “”moon face””. Other symptoms include sweating, polyuria, and hypertension, dilation of the capillaries, thinning of the skin, red striae, osteoporosis, diabetes mellitus, immune suppression, sleep disturbances, muscle weakness, hirsutism, baldness, and hypocalcemia. Cushing’s syndrome can broadly be classified into corticotropin-dependent Cushing’s syndrome and corticotropin-independent Cushing’s syndrome.

In-depth research report on “Global Cushing’s Syndrome Therapeutics Market”, Visit:

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Cushing’s Syndrome Therapeutics market for the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic, off-label, and branded therapies used in the treatment of Cushing’s syndrome caused in humans.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Cushing’s Syndrome Therapeutics market. In addition, the report discusses the major drivers that influence the growth of the market and also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

The report covers the Americas, and the EMEA and APAC regions; it also covers the Global BI and Analytics Platform market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas


• EMEA    

See More Reports of This Category by Radiant Insights:

Key Vendors

• Corcept Therapeutics

• HRA Pharma

• Novartis

Other Prominent Vendors

• Aspireo Pharmaceuticals

• Cortendo

• ElexoPharm

• Ipsen

• Isis Pharmaceuticals

• Orphagen Pharmaceuticals

• Samaritan Pharmaceuticals

Latest Report by Radiant Insights:

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Blog URL: http://www.terrapass.org/

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/global-cushing-s-syndrome-therapeutics-market-2015-2019

Comments are closed.